éå»1ã¶æéã«Eterna Therapeutics Incã«å¯ŸããŠè©äŸ¡ãåºããã¢ããªã¹ã1åã«åºã¥ãããŒã¿ã
仿ãERNAã¯1ä»¶ã®ãè²·ããã0ä»¶ã®ãäžç«ïŒããŒã«ãïŒãã0ä»¶ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããERNAã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯30.000ã§ãã
ã¢ããªã¹ãäºæ³ã«ãããšãFY2026Q2ã«çºè¡šãããEPS -3.396ã«ç¶ããERNAã®FY2026Q3ã®EPSã¯-3.840ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã